Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Gross Margin (2016 - 2025)

Historic Gross Margin for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to 64.43%.

  • Apyx Medical's Gross Margin rose 38900.0% to 64.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 62.65%, marking a year-over-year increase of 22400.0%. This contributed to the annual value of 61.04% for FY2024, which is 34500.0% down from last year.
  • According to the latest figures from Q3 2025, Apyx Medical's Gross Margin is 64.43%, which was up 38900.0% from 62.28% recorded in Q2 2025.
  • Over the past 5 years, Apyx Medical's Gross Margin peaked at 72.22% during Q4 2021, and registered a low of 58.07% during Q1 2024.
  • Its 5-year average for Gross Margin is 64.48%, with a median of 64.43% in 2025.
  • Its Gross Margin has fluctuated over the past 5 years, first soared by 183800bps in 2021, then plummeted by -68800bps in 2022.
  • Over the past 5 years, Apyx Medical's Gross Margin (Quarter) stood at 72.22% in 2021, then decreased by -10bps to 65.35% in 2022, then decreased by -7bps to 60.9% in 2023, then grew by 3bps to 63.03% in 2024, then grew by 2bps to 64.43% in 2025.
  • Its Gross Margin was 64.43% in Q3 2025, compared to 62.28% in Q2 2025 and 60.07% in Q1 2025.